Breast cancer associated fibroblasts (bCAFs) are dependent upon MCL-1 for survival and through secretion of IL-6, bCAFs can induce upregulation of MCL1 mRNA and protein in luminal breast cancer cells to reduce sensitivity to BCL-2/XL inhibition [133]. This evidence concerns the gene IL6 and breast carcinoma.